NewAmsterdam Pharma reported total assets of $704.45M and total liabilities of $73.03M for the quarter ended Jun 2026, down 13.6% year over year. This balance sheet covers 16 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2021 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Loans - NetNet Loans | 0.82M | |||||||||||||||
| Assets | ||||||||||||||||
| Current Assets | ||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 60.74M | 447.40M | 441.31M | 416.71M | 368.31M | 340.45M | 481.15M | 430.71M | 422.73M | 771.74M | 748.42M | 563.86M | 538.41M | 490.00M | 457.61M | 424.15M |
| Receivables - OtherOther Receivables | 0.88M | 3.98M | 2.13M | 1.65M | 1.75M | 1.44M | 3.29M | 3.90M | 6.76M | 8.02M | 5.11M | |||||
| Prepaid Assets | 6.61M | 9.81M | 6.28M | 6.34M | 6.67M | 14.64M | 15.14M | 24.27M | 8.83M | 30.69M | 28.07M | 38.14M | 20.60M | 24.00M | ||
| Current Assets | 67.35M | 457.21M | 423.88M | 346.79M | 487.82M | 445.35M | 437.87M | 863.41M | 817.30M | 769.85M | 732.33M | 675.70M | 658.04M | 659.21M | ||
| Non-Current Assets | ||||||||||||||||
| Property, Plant & Equipment (Net) | 1.04M | 85.14M | 0.12M | 0.05M | 0.10M | 0.23M | 0.23M | 0.24M | 0.24M | 0.31M | 0.32M | 0.38M | 0.38M | 0.41M | ||
| Long-Term Investments | 44.17M | 53.09M | 92.61M | 71.24M | 44.41M | |||||||||||
| Intangibles | 84.84M | 88.89M | ||||||||||||||
| Goodwill & Intangibles | 84.84M | 88.89M | 0.17M | 0.49M | 0.54M | 0.59M | 0.53M | 0.50M | 0.47M | 0.44M | 0.41M | 0.38M | 0.34M | |||
| Other Non-Current Assets | 0.15M | 0.10M | 0.04M | 0.02M | 0.01M | 2.58M | ||||||||||
| Non-Current Assets | 1.04M | 85.14M | 89.11M | 0.31M | 0.64M | 1.34M | 1.32M | 1.21M | 1.11M | 45.26M | 54.10M | 93.58M | 74.60M | 45.24M | ||
| Assets | 68.39M | 542.35M | 512.99M | 347.10M | 488.46M | 446.69M | 439.19M | 864.62M | 818.41M | 815.11M | 786.43M | 769.28M | 732.64M | 704.45M | ||
| Liabilities | ||||||||||||||||
| Current Liabilities | ||||||||||||||||
| Accounts Payables | 11.24M | 18.88M | 22.71M | 16.92M | 8.54M | 5.28M | 7.04M | 4.74M | 6.09M | 5.89M | 3.63M | 8.97M | 8.09M | 5.42M | ||
| Notes Payables | 3.97M | 8.41M | 12.57M | 33.06M | 23.55M | 18.90M | 37.51M | 23.52M | 20.93M | 44.36M | 57.27M | 50.23M | 54.45M | |||
| Payables | 11.24M | 22.84M | 31.12M | 29.50M | 41.60M | 28.82M | 25.94M | 42.26M | 29.61M | 26.83M | 47.99M | 66.24M | 58.32M | 59.87M | ||
| Accumulated Expenses | 6.12M | 11.40M | 9.97M | 10.19M | 10.58M | 13.61M | 8.02M | 9.46M | 10.10M | 15.42M | 5.09M | 10.28M | ||||
| Current Leases | 0.06M | 0.06M | 0.07M | 0.06M | 0.04M | 0.23M | 0.24M | 0.25M | 0.25M | 0.23M | 0.18M | 0.14M | 0.02M | 0.03M | ||
| Current Deferred Revenue | 4.58M | 3.18M | 9.96M | 8.12M | 6.06M | 4.50M | 6.01M | 3.03M | 3.99M | 3.99M | 2.80M | |||||
| Total Current Liabilities | 11.30M | 36.18M | 41.74M | 49.90M | 59.73M | 45.31M | 41.26M | 106.92M | 40.91M | 36.51M | 58.27M | 85.79M | 67.42M | 72.97M | ||
| Non-Current Liabilities | ||||||||||||||||
| Non-Current Deffered Revenue | 4.79M | 1.02M | 0.44M | 0.22M | ||||||||||||
| Operating Leases | 0.13M | 0.06M | 0.03M | 0.33M | 0.27M | 0.20M | 0.14M | 0.10M | 0.09M | 0.07M | 0.06M | |||||
| Other Non-Current Liabilities | 7.20M | 8.22M | 7.79M | 16.49M | 13.39M | 18.81M | 82.31M | 23.52M | 20.93M | 44.36M | 57.27M | 50.23M | 54.45M | |||
| Total Non-Current Liabilities | 0.13M | 11.84M | 11.43M | 50.92M | 60.17M | 45.86M | 41.52M | 24.81M | 17.53M | 15.68M | 14.00M | 28.58M | 17.19M | 18.58M | ||
| Total Liabilities | 11.43M | 48.01M | -398.41M | 53.18M | -331.83M | 58.70M | 76.66M | 59.25M | 60.33M | 107.12M | 41.05M | 36.62M | 58.36M | 85.85M | 67.42M | 73.03M |
| Shareholder's Equity | ||||||||||||||||
| Total Debt | 3.97M | 8.41M | 12.57M | 33.06M | 23.55M | 18.90M | 37.51M | 23.52M | 20.93M | 44.36M | 57.27M | 50.23M | 54.45M | |||
| Common Equity | 56.96M | 494.33M | 398.41M | 373.34M | 331.83M | 288.39M | 411.80M | 387.44M | 378.86M | 757.50M | 777.36M | 778.50M | 728.07M | 683.43M | 665.22M | 631.42M |
| Liabilities and Shareholders Equity | 68.39M | 542.35M | 512.99M | 347.10M | 488.46M | 446.69M | 439.19M | 864.62M | 818.41M | 815.11M | 786.43M | 769.28M | 732.64M | 704.45M | ||
| Retained Earnings | -39.67M | -121.78M | -211.76M | -316.97M | -410.74M | -449.75M | -466.39M | -558.57M | -598.10M | -615.46M | -687.47M | -762.39M | -810.83M | -874.97M |